2022 WHO 政策声明:使用替代的干扰素释放试验诊断结核感染

2022-01-28 世界卫生组织 WHO官网

在审查了技术咨询小组 (TAG) 关于结核病 (TB) 诊断和实验室强化的证据和建议后,世界卫生组织 (WHO) 宣布,目前 WHO 关于使用干扰素-γ 释放测定法 (IGRA) 的建议也

中文标题:

2022 WHO 政策声明:使用替代的干扰素释放试验诊断结核感染

英文标题:

Use of alternative interferon-gamma release assays for the diagnosis of TB infection: WHO policy statement

发布机构:

世界卫生组织

发布日期:

2022-01-28

简要介绍:

在审查了技术咨询小组 (TAG) 关于结核病 (TB) 诊断和实验室强化的证据和建议后,世界卫生组织 (WHO) 宣布,目前 WHO 关于使用干扰素-γ 释放测定法 (IGRA) 的建议也是适用于北京万泰的 TB-IGRAQiagen QuantiFERON-TB Gold Plus产品。这扩大了可用于检测 TB 感染的测试范围。本世卫组织政策声明提供了全部详细信息。

相关资料下载:
[AttachmentFileName(sort=1, fileName=9789240042346-eng.pdf)] GetToolGuiderByIdResponse(projectId=1, id=be2a01c002a935b8, title=2022 WHO 政策声明:使用替代的干扰素释放试验诊断结核感染, enTitle=Use of alternative interferon-gamma release assays for the diagnosis of TB infection: WHO policy statement, guiderFrom=WHO官网, authorId=0, author=, summary=在审查了技术咨询小组 (TAG) 关于结核病 (TB) 诊断和实验室强化的证据和建议后,世界卫生组织 (WHO) 宣布,目前 WHO 关于使用干扰素-&gamma; 释放测定法 (IGRA) 的建议也, cover=https://img.medsci.cn/20220630/1656596399489_1608702.png, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Fri Jan 28 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #1a1a1a;"><span>在审查了技术咨询小组 (TAG) 关于结核病 (TB) 诊断和实验室强化的证据和建议后,世界卫生组织 (WHO) 宣布,目前 WHO 关于使用干扰素-&gamma; 释放测定法 (IGRA) 的建议也是适用于</span></span><strong style="color: #1a1a1a;"><span>北京万泰的 TB-IGRA</span></strong><span style="color: #1a1a1a;"><span>和</span></span><strong style="color: #1a1a1a;"><span>Qiagen QuantiFERON-TB Gold Plus</span></strong><span style="color: #1a1a1a;"><span>产品。</span><span>这扩大了可用于检测 TB 感染的测试范围。</span><span>本世卫组织政策声明提供了全部详细信息。</span></span></p>, tagList=[TagDto(tagId=1564, tagName=干扰素), TagDto(tagId=13190, tagName=结核感染), TagDto(tagId=439921, tagName=干扰素-γ 释放测定法)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=69, categoryName=检验病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=政策, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1873, appHits=18, showAppHits=0, pcHits=271, showPcHits=1855, likes=1, shares=0, comments=1, approvalStatus=1, publishedTime=Thu Jun 30 21:38:20 CST 2022, publishedTimeString=2022-01-28, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Thu Jun 30 21:41:33 CST 2022, updatedBy=4754896, updatedName=小小医者, updatedTime=Fri Jan 05 23:11:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=9789240042346-eng.pdf)])
9789240042346-eng.pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1249473, encodeId=90ce12494e321, content=<a href='/topic/show?id=daeb48e14ef' target=_blank style='color:#2F92EE;'>#干扰素#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48714, encryptionId=daeb48e14ef, topicName=干扰素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:12:52 CST 2022, time=2022-09-17, status=1, ipAttribution=)]